![Chen Schor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chen Schor
Directeur Général chez
ADICET BIO, INC.
Fortune : 106 227 $ au 31/05/2026
Profil
Chen Schor was the founder of resTORbio, Inc., founded in 2016, serving as President, CEO, CFO, Secretary & Director in 2020.
Current jobs include President, Chief Executive Officer & Director at Adicet Bio, Inc. since 2016; Chairman at Carbon Biosciences, Inc.; Director at Otic Pharma Ltd.; Director at Alliance for Cancer Gene Therapy, Inc.; and Independent Director at Karyopharm Therapeutics, Inc. since 2020.
Former jobs include President, Chief Executive Officer & Director at Synta Pharmaceuticals Corp.
from 2015 to 2016; President, Chief Executive Officer & Director at Novalere, Inc.; President, Chief Executive Officer & Director at Adicet Therapeutics, Inc.; Director at Brainstorm Cell Therapeutics, Inc. from 2011 to 2020; Director at Gelesis, Inc.; Director at Cerapedics, Inc.; Director at Quiet Therapeutics Ltd.; Vice President-Business Development at Teva Pharmaceutical Industries Ltd. from 2009 to 2011; Chief Business Officer at EPIX Pharmaceuticals, Inc. from 2003 to 2009; Chief Business Officer at Predix Pharmaceuticals, Inc. from 2003 to 2009; VP-Business Development, Global Branded Products at Teva Pharmaceuticals USA, Inc. from 2009 to 2011; Partner at XT Hi-Tech Investments (1992) Ltd. from 1998 to 2003; Principal at Arthur Anderson & Co.; Chief Business Officer at Sesen Bio, Inc. from 2011 to 2012; and Partner at Yozma Venture Capital Ltd. Education includes undergraduate and MBA degrees from Tel-Aviv University and an undergraduate degree from the University of Haifa.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADICET BIO INC 0,12 % | 27/04/2026 | 11 410 ( 0,12 % ) | 106 227 $ | 31/05/2026 |
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Chen Schor
| Sociétés | Poste | Début |
|---|---|---|
| ADICET BIO, INC. | Directeur Général | 01/07/2016 |
| KARYOPHARM THERAPEUTICS INC. | Directeur/Membre du Conseil | 25/11/2020 |
Carbon Biosciences, Inc.
 Carbon Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops genetic medicines for the treatment of devastating diseases | Président | - |
Alliance for Cancer Gene Therapy, Inc.
 Alliance for Cancer Gene Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for cancer research | Directeur/Membre du Conseil | - |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Directeur/Membre du Conseil | - |
Anciens postes connus de Chen Schor
| Sociétés | Poste | Fin |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur/Membre du Conseil | 30/03/2020 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Directeur Général | 22/07/2016 |
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2012 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/09/2011 |
| ░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Chen Schor
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Cerapedics, Inc.
 Cerapedics, Inc. Medical/Nursing ServicesHealth Services Operates as an orthopedics company that develops bone repair products | Health Services |
Novalere, Inc.
 Novalere, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Yozma Venture Capital Ltd.
 Yozma Venture Capital Ltd. Investment ManagersFinance Venture Capital Fund | Finance |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
XT Hi- Tech Investments (1992) Ltd. | |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Health Technology |
Alliance for Cancer Gene Therapy, Inc.
Alliance for Cancer Gene Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for cancer research | Commercial Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Arthur Anderson & Co. | |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
University of Haifa
 University of Haifa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quiet Therapeutics Ltd.
 Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs | Health Technology |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Adicet Bio, Inc.
 Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
Carbon Biosciences, Inc.
Carbon Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops genetic medicines for the treatment of devastating diseases | Health Technology |
